Bagley Scott W, Southers James A, Cabral Shawn, Rose Colin R, Bernhardson David J, Edmonds David J, Polivkova Jana, Yang Xiaojing, Kung Daniel W, Griffith David A, Bader Scott J
Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, USA.
J Org Chem. 2012 Feb 3;77(3):1497-506. doi: 10.1021/jo202377g. Epub 2012 Jan 25.
Synthesis of oxo-dihydrospiroindazole-based acetyl-CoA carboxylase (ACC) inhibitors is reported. The dihydrospiroindazoles were assembled in a regioselective manner in six steps from substituted hydrazines and protected 4-formylpiperidine. Enhanced regioselectivity in the condensation between a keto enamine and substituted hydrazines was observed when using toluene as the solvent, leading to selective formation of 1-substituted spiroindazoles. The 2-substituted spiroindazoles were formed selectively from alkyl hydrazones by ring closure with Vilsmeier reagent. The key step in the elaboration to the final products is the conversion of an intermediate olefin to the desired ketone through elimination of HBr from an O-methyl bromohydrin. This methodology enabled the synthesis of each desired regioisomer on 50-75 g scale with minimal purification. Acylation of the resultant spirocyclic amines provided potent ACC inhibitors.
报道了基于氧代二氢螺吲哚并吡唑的乙酰辅酶A羧化酶(ACC)抑制剂的合成。二氢螺吲哚并吡唑由取代肼和受保护的4-甲酰基哌啶通过六步区域选择性组装而成。当使用甲苯作为溶剂时,在酮烯胺与取代肼之间的缩合反应中观察到区域选择性增强,导致选择性形成1-取代的螺吲哚并吡唑。2-取代的螺吲哚并吡唑通过与Vilsmeier试剂闭环,由烷基腙选择性形成。最终产物制备中的关键步骤是通过从O-甲基溴代醇中消除HBr,将中间体烯烃转化为所需的酮。该方法能够以50-75克规模合成每种所需的区域异构体,且纯化步骤最少。所得螺环胺的酰化提供了有效的ACC抑制剂。